A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

Clinical trial NCT02610283 · COMPLETED

Trial details

NCT number: NCT02610283
Sponsor: Quark Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Kidney Injury

Start date: 2015-12-01
Primary completion: 2018-02-01
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.